Clinical Trials
The APDA Information & Referral Center at Boston University School of Medicine is pleased to maintain this listing of ongoing clinical trials for convenient access to basic information on research studies at various movement disorder centers in Massachusetts. Although APDA has not individually reviewed or specifically endorsed each study posted here, each has been reviewed and approved by the Institutional Review Board at its respective medical center.
For further information on any study posted here, please utilize the specific contact information provided with the description of the actual study in which you are interested. As always, consult your physician to discuss the individual benefits and risks of each study prior to participating.
If you’re interested in learning more about the benefits of research in Parkinson’s in general, check out this webinar from the APDA MA, recorded on November 2, 2021.
To submit trial information please correspond with Cathi Thomas RN, MS at apdama@apdaparkinson.org.
Clinical Trials in Massachusetts
A Multicenter Phase 2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UCB0022 in Study Participants with Advanced Parkinson’s Disease
Speech Accessibility Project
Peer coaching to improve physical activity in older Latinx adults with Parkinson’s disease – In English & Español
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson’s Disease (LUMA) – 2 Sites
PD GENEration
NeuroVision™: A Smartphone Application for Neurology and Telemedicine
Communication Intervention Research Study for People with PD and Care Partners
Barriers and Motivators Associated with Access to Care and Participation in Research Studies for Parkinson’s Disease Among Asian Americans
Perception in Parkinson’s Disease
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial (SPARX 3)
Parkinson’s Progression Markers Initiative Study (PPMI)
wAID-P Study
Portable Brain MRI Study
Effectiveness of SPEAK OUT! and LOUD Crowd programs on speech intelligibility and communicative participation in Parkinson’s disease
Trial of Parkinson’s and Zoledronic Acid (TOPAZ) – 2 Sites
Bright Light Modulation of Non-Motor Symptoms in Parkinson’s Disease
Early Longitudinal Imaging in a Parkinson’s Progression Markers Initiative (PPMI)
Lipid Markers for Parkinson’s and Memory
STEPP Lab Study
Freezing of Gait
Last Updated 11/13/2024